Form 4 for PIII P3 Health Partners Inc.

Accepted 2024-06-26 00:00:00 ET · period of report 2024-05-24 · accession 0000950170-24-077900 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2024-06-26	2024-05-24	PIII	LEAVITT LEGACY, LLC	10%	P - Purchase	—	+7.97M	16.92M	+89%	—
DI	2024-06-26	2024-05-24	PIII	LEAVITT LEGACY, LLC	10%	P - Purchase	—	+7.97M	7.97M	New	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2024-05-24	P	A	7,974,481	—	16,919,024	I By Leavitt Equity Partners III, L.P.	—	—	(F1) The reported securities were issued in connection with the Issuer's sale of 7,974,481 Units purchased by the Reporting Person for $0.6270 per Unit. Each Unit consists of (i) one share of Class A Common Stock and (ii) one warrant to purchase one share of Class A Common Stock. The Units were issued directly to Leavitt Equity Partners III, L.P., of which Leavitt Equity Partners III, LLC is the general partner.
2	Derivative	Warrant	2024-05-24	P	A	7,974,481	—	7,974,481	I By Leavitt Equity Partners III, L.P.	$0.5 · — to 2031-05-24	7,974,481 Class A Common Stock	(F1) The reported securities were issued in connection with the Issuer's sale of 7,974,481 Units purchased by the Reporting Person for $0.6270 per Unit. Each Unit consists of (i) one share of Class A Common Stock and (ii) one warrant to purchase one share of Class A Common Stock. The Units were issued directly to Leavitt Equity Partners III, L.P., of which Leavitt Equity Partners III, LLC is the general partner. (F2) Exercisable Immediately.